Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Molecule targets and kills tumor cells, starves blood supply

16.03.2006


A man-made chemical compound called ARC causes tumor cells to die but leaves normal cells unharmed, researchers at the University of Illinois at Chicago report in a study highlighted in the March 15 issue of Cancer Research. ARC also proved to have strong anti-angiogenic properties, showing promise as an inhibitor of new blood vessel formation in tumors.



ARC, an acronym for its long chemical name, resembles one of the bases that are the building blocks of DNA. Researchers found it by screening more than 2,000 compounds for their ability to inhibit a key step in the cell cycle. Previous studies had shown that blocking that step spurs apoptosis, or cell suicide, in cancer cells.

When cancer cells (human lung cells that had been transformed by a virus to become cancerous) were treated with ARC, 50 to 70 percent killed themselves within 24 hours. Normal lung cells exposed to two to four times higher concentrations of ARC were unharmed.


"Our results suggest that while ARC induces cell death in tumor cells very efficiently, it only causes a cell-cycle block in normal cells," said Andrei Gartel, assistant professor of molecular genetics at UIC and principal investigator on the study. "This gives ARC an important advantage as a potential anticancer drug, because many of the drugs currently used to fight cancer are also toxic to normal cells."

In other experiments, Gartel said, ARC induced cell suicide in breast, colon, gastric and liver cancer cell lines.

An important aspect of ARC-induced cell suicide, Gartel said, is that it does not rely on p53, a normal protein in cells that is often responsible for initiating cell death after the cell has been treated with cancer drugs. The problem, he said, is that in more than half of all human tumors p53 has been inactivated.

Gartel said while it is not yet known how ARC induces apoptosis in cancer cells, his group has shown that in normal cells the molecule inhibits RNA synthesis, a key step in gene expression.

"One possible reason for ARC’s effect on cell death may be that cancer cell lines are more dependent on the protective effect of particular molecules to survive, and when those become less abundant after ARC treatment, the tumor cells undergo apoptosis," he said. "We are continuing our investigation of ARC’s mechanism of action."

To test whether ARC could also inhibit blood vessel formation in tumors, scientists at the National Cancer Institute performed three different angiogenesis assays. In all three assays, Gartel said, ARC performed "in the range of effectiveness" of a compound already in clinical trials as an anti-angiogenic agent.

"We think ARC may have potential as an anti-cancer drug," said Gartel. "Here we have a compound that induces cell death in tumors, but not in normal cells, and is highly anti-angiogenic. We have already begun to explore its potential against a range of different types of tumors."

The researchers now must test ARC against other cell lines in the laboratory and perform further preliminary animal experiments before human trials could be planned. Only a tiny fraction of promising candidate drugs enter clinical trials, and few of those are approved.

UIC research specialist Senthil Radhakrishnan is co-author of the study. The study was funded by the UIC Department of Medicine, the Illinois Department of Public Health and the National Institutes of Health.

UIC ranks among the nation’s top 50 universities in federal research funding and is Chicago’s largest university with 25,000 students, 12,000 faculty and staff, 15 colleges and the state’s major public medical center. A hallmark of the campus is the Great Cities Commitment, through which UIC faculty, students and staff engage with community, corporate, foundation and government partners in hundreds of programs to improve the quality of life in metropolitan areas around the world.

Jeanne Galatzer-Levy | EurekAlert!
Further information:
http://www.uic.edu

More articles from Life Sciences:

nachricht Cnidarians remotely control bacteria
21.09.2017 | Christian-Albrechts-Universität zu Kiel

nachricht Immune cells may heal bleeding brain after strokes
21.09.2017 | NIH/National Institute of Neurological Disorders and Stroke

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Comet or asteroid? Hubble discovers that a unique object is a binary

21.09.2017 | Physics and Astronomy

Cnidarians remotely control bacteria

21.09.2017 | Life Sciences

Monitoring the heart's mitochondria to predict cardiac arrest?

21.09.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>